August 10, 2009 11:19 ET

OPTIMIZERx Corp. Announces the Addition of WebMD Co-Founder and Former President as Advisor

ROCHESTER, MI--(Marketwire - August 10, 2009) - OPTIMIZERx Corporation (PINKSHEETS: OPRX), a web-based technology group providing patients and consumers with useful information about their medical conditions, available savings and relevant patient support programs, has announced the addition of Blake Whitney, CEO of BW Advisors, to the company's board of advisors. Mr. Whitney brings with him a proven health care related track record and industry insights that will prove beneficial to the Company.

Mr. Whitney, best known for co-founding WebMD, brings extensive expertise in the web-centric health information industry. "I am proud to join OPTIMIZERx as an advisor. Their business model and focus of providing better access to better health care and their commitment to providing savings for the consumer is a valuable business proposition. Given the Company's market proposition, my track record for health related IT and building of shareholder value, I believe we have a winning combination," stated Mr. Whitney.

"We are understandably excited to be able to team up with Blake," remarked David Lester, Chief Executive Officer of OPTIMIZERx. "Blake's strategic vision, his record of successfully executing and bringing novel solutions to the health care market make him a valuable addition to our team."

About OPTIMIZERx Corporation.

OPTIMIZERx provides unique platforms to help patients better afford and comply to their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company's web-based consumer information and patient support website,, and its permanent subscriber base, continues to grow each month and is quickly becoming the preferred way to access branded prescription savings and support programs. Additionally, OPTIMIZERx has integrated and developed peripheral offerings and capabilities, most obviously the launch of OFFERx™ and ADHERxE offer management system to allow more brands to participate in promoting a new trial or co-pay program, as well as sophisticated online behavioural re-targeting and database marketing of brand-name pharmaceuticals, OTC medications, medical devices, and healthcare services that provide OPTIMIZERx visitors and subscribers the highest possible value and the best possible medical outcome for their specific condition.


This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an Investment decision. The words 'estimate,' 'possible,' 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact Information